MaxCyte Inc. (MXCT)
NASDAQ: MXCT
· Real-Time Price · USD
2.15
0.00 (0.00%)
At close: Jun 06, 2025, 3:03 PM
MaxCyte Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Product and Service, Other Revenue | 1.13M |
| Product and Service, Other Revenue Growth | n/a |
| Product Revenue | 21.09M |
| Product Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Non-Us Revenue | 12.86M |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 25.77M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 14.22M | 13.68M | 13.95M | 14.23M | 14.44M | 15.26M | 13.87M | 14.1M | 13.79M | 11.03M | 10.95M | 12.03M | 10.47M | 10.06M | 8.86M | 7.54M | 5.79M | 5.1M | 4.35M | 3.44M | 3.83M | 3.14M | 3.67M | 3.3M | 3.3M | 3.13M | 3.13M | 2.87M | 2.87M | 2.59M | 2.59M | 2.68M | 2.68M | 2.6M | 2.6M | 1.9M | 1.9M | 1.56M | 1.56M | 1.44M | 1.44M |
| Selling, General, and Administrative Revenue Growth | +3.98% | -1.96% | -1.95% | -1.43% | -5.43% | +10.08% | -1.64% | +2.20% | +25.11% | +0.68% | -8.99% | +14.92% | +4.10% | +13.48% | +17.63% | +30.21% | +13.54% | +17.12% | +26.58% | -10.15% | +21.83% | -14.49% | +11.42% | 0.00% | +5.35% | 0.00% | +8.87% | 0.00% | +10.88% | 0.00% | -3.16% | 0.00% | +3.14% | 0.00% | +36.67% | 0.00% | +21.43% | 0.00% | +8.46% | 0.00% | n/a |
| Research and Development Revenue | 5.9M | 4.61M | 5.32M | 5.62M | 6.68M | 5.84M | 6.26M | 5.66M | 6.05M | 5.73M | 5.33M | 4.7M | 3.77M | 3.38M | 2.77M | 3.21M | 6.08M | 4.89M | 4.52M | 4.09M | 4.24M | 3.94M | 3.95M | 4.85M | 4.85M | 3.17M | 3.17M | 2.46M | 2.46M | 3.55M | 3.55M | 2.1M | 2.1M | 1.32M | 1.32M | 1.03M | 1.03M | 784.2K | 784.2K | 719.85K | 719.85K |
| Research and Development Revenue Growth | +27.94% | -13.21% | -5.39% | -15.86% | +14.31% | -6.74% | +10.59% | -6.32% | +5.56% | +7.57% | +13.40% | +24.72% | +11.37% | +21.85% | -13.44% | -47.25% | +24.22% | +8.27% | +10.45% | -3.64% | +7.62% | -0.23% | -18.45% | 0.00% | +53.13% | 0.00% | +28.88% | 0.00% | -30.73% | 0.00% | +69.16% | 0.00% | +58.60% | 0.00% | +28.77% | 0.00% | +30.89% | 0.00% | +8.94% | 0.00% | n/a |
| Sales and Marketing Revenue | 5.7M | 6.47M | 6.21M | 6.62M | 7.37M | 7.2M | 7.05M | 6.44M | 6.3M | 5.38M | 4.51M | 4.93M | 3.84M | 4.09M | 3.21M | 2.91M | 2.79M | 2.4M | 2.04M | 1.84M | 2.05M | 2.01M | 2.01M | 1.91M | 1.91M | 1.73M | 1.73M | 1.63M | 1.63M | 1.53M | 1.53M | 1.47M | 1.47M | 1.4M | 1.4M | 988.5K | 988.5K | 912.45K | 912.45K | 759.75K | 759.75K |
| Sales and Marketing Revenue Growth | -11.96% | +4.27% | -6.20% | -10.16% | +2.35% | +2.11% | +9.49% | +2.22% | +17.10% | +19.31% | -8.60% | +28.44% | -6.13% | +27.34% | +10.25% | +4.44% | +16.42% | +17.49% | +10.58% | -10.06% | +1.79% | 0.00% | +5.33% | 0.00% | +10.26% | 0.00% | +6.53% | 0.00% | +6.09% | 0.00% | +4.09% | 0.00% | +5.02% | 0.00% | +41.99% | 0.00% | +8.33% | 0.00% | +20.10% | 0.00% | n/a |